Home Healthcare Biotechnology Shingles Vaccine Market

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Shingles Vaccine Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Shingrix
    2. Zostavax
    3. SKYZoster
  2. Shingles Vaccine Market, By Vaccine Type 2022-2034 (USD MILLION/ Units)
    1. Recombinant Vaccine
    2. Live Attenuated Vaccine
  3. Regional Shingles Vaccine Market
    1. North America
      1. North America Shingles Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      2. North America Shingles Vaccine Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
      3. U.S.
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      4. Canada
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
    2. Europe
      1. Europe Shingles Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      2. Europe Shingles Vaccine Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
      3. U.K.
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      4. Germany
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      5. France
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      6. Spain
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      7. Italy
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      8. Russia
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      9. Nordic
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      10. Benelux
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      11. Rest of Europe
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
    3. APAC
      1. APAC Shingles Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      2. APAC Shingles Vaccine Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
      3. China
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      4. Korea
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      5. Japan
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      6. India
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      7. Australia
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      8. Singapore
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      9. Taiwan
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      10. South East Asia
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      11. Rest of Asia-Pacific
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
    4. Middle East and Africa
      1. Middle East and Africa Shingles Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      2. Middle East and Africa Shingles Vaccine Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
      3. UAE
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      4. Turkey
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      5. Saudi Arabia
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      6. South Africa
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      7. Egypt
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      8. Nigeria
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      9. Rest of MEA
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
    5. LATAM
      1. LATAM Shingles Vaccine Market By Product 2022-2034 (USD MILLION/ Units)
        1. Shingrix
        2. Zostavax
        3. SKYZoster
      2. LATAM Shingles Vaccine Market By Vaccine Type 2022-2034 (USD MILLION/ Units)
        1. Recombinant Vaccine
        2. Live Attenuated Vaccine
      3. Brazil
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      4. Mexico
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      5. Argentina
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      6. Chile
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      7. Colombia
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
      8. Rest of LATAM
        1. Shingrix
        2. Zostavax
        3. SKYZoster
        4. Recombinant Vaccine
        5. Live Attenuated Vaccine
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.